Eloxx Pharmaceuticals, Inc. SEC filings ELOX

Eloxx Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Dec 23, 2008. Its latest annual report, Form 10-K, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
10-Q Quarterly report May 6, 2022 Mar 31, 2022
10-Q Quarterly report Nov 8, 2021 Sep 30, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
10-Q Quarterly report May 7, 2021 Mar 31, 2021
10-Q Quarterly report Nov 6, 2020 Sep 30, 2020
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
10-Q Quarterly report May 8, 2020 Mar 31, 2020
10-Q Quarterly report Nov 6, 2019 Sep 30, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
10-Q Quarterly report Nov 8, 2018 Sep 30, 2018
10-Q Quarterly report Aug 10, 2018 Jun 30, 2018
10-Q Quarterly report May 10, 2018 Mar 31, 2018
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
10-Q Quarterly report May 22, 2017 Mar 31, 2017
10-Q Quarterly report Feb 10, 2017 Dec 31, 2016
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
10-Q Quarterly report May 12, 2016 Mar 31, 2016
10-Q Quarterly report Feb 16, 2016 Dec 31, 2015
10-Q Quarterly report Nov 16, 2015 Sep 30, 2015
10-Q Quarterly report May 14, 2015 Mar 31, 2015
10-Q Quarterly report Feb 17, 2015 Dec 31, 2014
10-Q Quarterly report Nov 14, 2014 Sep 30, 2014
10-Q Quarterly report May 9, 2014 Mar 31, 2014
10-Q Quarterly report Feb 14, 2014 Dec 31, 2013
10-Q Quarterly report Nov 14, 2013 Sep 30, 2013
10-Q Quarterly report May 15, 2013 Mar 31, 2013
10-Q Quarterly report Feb 14, 2013 Dec 31, 2012
10-Q Quarterly report Nov 14, 2012 Sep 30, 2012
10-Q Quarterly report May 14, 2012 Mar 31, 2012
10-Q Quarterly report Feb 14, 2012 Dec 31, 2011
10-Q Quarterly report Nov 14, 2011 Sep 30, 2011
10-Q Quarterly report May 13, 2011 Mar 31, 2011
10-Q Quarterly report Feb 10, 2011 Dec 31, 2010
10-Q Quarterly report Nov 15, 2010 Sep 30, 2010
10-Q Quarterly report May 17, 2010 Mar 31, 2010
10-Q Quarterly report Feb 16, 2010 Dec 31, 2009
10-Q Quarterly report Nov 16, 2009 Sep 30, 2009
10-Q Quarterly report May 1, 2009 Mar 31, 2009
10-Q Quarterly report Feb 17, 2009 Dec 31, 2008

Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ELOX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Arlington, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1035354
Former names
Sevion Therapeutics, Inc. (until Dec 22, 2017); SENESCO TECHNOLOGIES INC (until Sep 29, 2014); NAVA LEISURE USA INC (until May 24, 1999)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.